Gist Healthcare Daily

Johnson & Johnson draws the ire of hospitals and the government over a planned change to how it will provide discounts for some of its 340B-eligible drugs. Pfizer becomes the second drug company to get into the direct-to-consumer market. Those stories and more coming up on today’s episode of the Gist Healthcare podcast.

Struggling Steward Health Care will sell six of its Massachusetts hospitals. Kaiser Permanente backed Risant Health plans to invest more than $1 billion dollars in Cone Health. And, pharmacy benefit manager leaders could be in hot water following testimony over their business practices on Capitol Hill. That’s coming up on today’s episode of the Gist Healthcare podcast. 

A new report projects the average cost of employer-sponsored health plans to rise 9 percent next year. The Centers for Medicare and Medicaid Services receives 12,000-plus complaints about No Surprises noncompliance. And, the FDA approves a chemo-free treatment for a common type of lung cancer. That’s coming up on today’s episode of Gist Healthcare Daily. 

A federal judge blocks the FTC’s ban on noncompetes. And, New Jersey’s governor says about $100 million dollars in residents’ medical debt will be eliminated. That’s coming up on today’s episode of Gist Healthcare Daily. 

Massachusetts’ governor arranges deals to force the sale of five Steward Health Care hospitals in the state. As Medicare Advantage enrollment grows, a new report warns of the program’s impact on hospital margins. And Eili Lilly's GLP-1 weight-loss drug reduces the risk of developing type 2 diabetes. That’s coming up on today’s episode of Gist Healthcare Daily. 

A Texas court overturns a HHS change to how Medicare pays hospitals that serve large numbers of low-income patients. Medical-cost fiduciary litigation is on the rise. And the FDA authorizes the first over-the-counter, at-home syphilis test. That’s coming up on today’s episode of Gist Healthcare Daily. 

Biden’s nursing home staffing mandate gets hit with another lawsuit. This one from the Texas attorney general. Eli Lilly takes action to halt the sales of copycats of its GLP-1 drugs. And Kentucky is the first state to decriminalize medical errors. That’s coming up on today’s episode of Gist Healthcare Daily. 

CMS releases results from its first Medicare prescription drug price negotiations under a new federal program. The WHO declares mpox a global public health emergency. And Elevance Health closes a deal with a private equity firm to create a primary care company. That’s coming up on today’s episode of Gist Healthcare Daily. 

Steward Health Care signs a definitive agreement to sell its physician group. President Biden announces $150 million dollars in federal awards as part of his “cancer moonshot.” And with no federal AI guidelines on the books, states create their own. That’s coming up on today’s episode of Gist Healthcare Daily.